tiprankstipranks
Trending News
More News >
Kalaris Therapeutics, Inc. (KLRS)
:KLRS
US Market

Kalaris Therapeutics (KLRS) Income Statement

Compare
343 Followers

Kalaris Therapeutics Income Statement

Last quarter (Q4 2023), Kalaris Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kalaris Therapeutics's net income was $-3.47M. See Kalaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 165.00K
Gross Profit
$ 0.00$ 0.00$ -1.12M$ -73.00K$ 165.00K
Operating Expenses
$ 13.46M$ 14.01M$ 169.82M$ 71.31M$ 26.87M
Depreciation and Amortization
$ 0.00$ 0.00$ 1.12M$ 73.00K$ 19.00K
EBITDA
$ -14.01M$ -15.25M$ -169.84M$ -69.71M$ -26.68M
Operating Income
$ -13.46M$ -14.01M$ -169.82M$ -71.31M$ -26.70M
Other Income/Expenses
$ -1.24M$ -1.48M$ -1.14M$ 1.52M$ 2.86M
Pretax Income
$ -14.70M$ -15.48M$ -170.96M$ -69.78M$ -23.84M
Net Income
$ -14.70M$ -15.48M$ -171.96M$ -68.38M$ -21.77M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ -2.74$ -2.54$ -0.33
Diluted EPS
$ 0.00$ 0.00$ -2.74$ -2.54$ -0.33
Weighted Average Shares Outstanding
0.00 0.00 62.78M 26.90M 65.11M
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 62.78M 26.90M 65.11M
Currency in USD

Kalaris Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis